| Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities M Sedighi, A Zahedi Bialvaei, MR Hamblin, E Ohadi, A Asadi, ... Cancer medicine 8 (6), 3167-3181, 2019 | 237 | 2019 |
| Bacteriocins: properties and potential use as antimicrobials A Darbandi, A Asadi, M Mahdizade Ari, E Ohadi, M Talebi, M Halaj Zadeh, ... Journal of Clinical Laboratory Analysis 36 (1), e24093, 2022 | 156 | 2022 |
| A review on anti-adhesion therapies of bacterial diseases A Asadi, S Razavi, M Talebi, M Gholami Infection 47, 13-23, 2019 | 128 | 2019 |
| A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus S Khoshnood, M Heidary, A Asadi, S Soleimani, M Motahar, M Savari, ... Biomedicine & Pharmacotherapy 109, 1809-1818, 2019 | 127 | 2019 |
| Obesity and gut–microbiota–brain axis: A narrative review A Asadi, N Shadab Mehr, MH Mohamadi, F Shokri, M Heidary, ... Journal of clinical laboratory analysis 36 (5), e24420, 2022 | 73 | 2022 |
| Clofazimine: A useful antibiotic for drug-resistant tuberculosis R Mirnejad, A Asadi, S Khoshnood, H Mirzaei, M Heidary, L Fattorini, ... Biomedicine & Pharmacotherapy 105, 1353-1359, 2018 | 70 | 2018 |
| Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: Back to the future A Asadi, M Abdi, E Kouhsari, P Panahi, M Sholeh, N Sadeghifard, ... Journal of global antimicrobial resistance 22, 161-174, 2020 | 59 | 2020 |
| The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010–20 A Darbandi, A Asadi, R Ghanavati, R Afifirad, AD Emamie, M Talebi International Journal of Infectious Diseases 105, 91-104, 2021 | 54 | 2021 |
| COVID‐19 in HIV‐positive patients: a systematic review of case reports and case series M Heidary, A Asadi, N Noorbakhsh, S Dashtbin, P Asadollahi, ... Journal of Clinical Laboratory Analysis 36 (4), e24308, 2022 | 22 | 2022 |
| Interesting probiotic traits of mother's milk Lactobacillus isolates; from bacteriocin to inflammatory bowel disease improvement M Abdi, V Lohrasbi, A Asadi, M Esghaei, FM Jazi, M Rohani, M Talebi Microbial Pathogenesis 158, 104998, 2021 | 20 | 2021 |
| The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis M Shirani, R Pakzad, MH Haddadi, S Akrami, A Asadi, H Kazemian, ... BMC Infectious Diseases 23 (1), 543, 2023 | 19 | 2023 |
| Antimicrobial resistance, prevalence of resistance genes, and molecular characterization in intestinal Bacteroides fragilis group isolates E Kouhsari, N Mohammadzadeh, MG Kashanizadeh, MM Saghafi, ... Apmis 127 (6), 454-461, 2019 | 19 | 2019 |
| Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV E Taki, F Soleimani, A Asadi, H Ghahramanpour, A Namvar, M Heidary Expert Review of Anti-infective Therapy 20 (8), 1135-1147, 2022 | 17 | 2022 |
| The effect of improved formulation of chitosan-alginate microcapsules of Bifidobacteria on serum lipid profiles in mice V Lohrasbi, M Abdi, A Asadi, M Rohani, M Esghaei, M Talebi, ... Microbial Pathogenesis 149, 104585, 2020 | 16 | 2020 |
| Clinical symptoms, diagnosis, treatment, and outcome of COVID‐19‐associated encephalitis: A systematic review of case reports and case series M Koupaei, N Shadab Mehr, MH Mohamadi, A Asadi, ... Journal of clinical laboratory analysis 36 (5), e24426, 2022 | 15 | 2022 |
| Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: a systematic review and meta-analysis T Azimi, S Khoshnood, A Asadi, M Heidary, H Mahmoudi, VH Kaviar, ... Frontiers in pharmacology 13, 955050, 2022 | 11 | 2022 |
| The diversity of class B and class D carbapenemases in clinical Acinetobacter baumannii isolates M Gholami, M Moshiri, M Ahanjan, A Salimi Chirani, ... Infez. Med 26, 329-335, 2018 | 11 | 2018 |
| Sleep disorders and it, s risk factors in nurses E Razmpa, M Ghaffarpour, KH Sadeghniiat Haghighi, HA Ghelichnia, ... Occupational medicine quarterly journal 1 (1), 20-23, 2009 | 10 | 2009 |
| Microbiological detoxification of mycotoxins: focus on mechanisms and advances M Abdi, A Asadi, F Maleki, E Kouhsari, A Fattahi, E Ohadi, E Lotfali, ... Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2021 | 9 | 2021 |
| The probiotic properties and potential of vaginal Lactobacillus spp. isolated from healthy women against some vaginal pathogens A Asadi, V Lohrasbi, M Abdi, S Mirkalantari, M Esghaei, M Kashanian, ... Letters in Applied Microbiology 74 (5), 752-764, 2022 | 7 | 2022 |
Malihe TalebiProfessor of Medical Bacteriology, Iran university of medical sciences在 iums.ac.ir 的电子邮件经过验证
